EUVIMEDEUVIMED entdecken
Klinische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort

David Wullimann iD, John Tyler Sandberg, Mira Akber, Marie Löfling, Sara Gredmark-Russ, Jakob Michaëlsson, Marcus Buggert, Kim Blom, Hans-Gustaf Ljunggren iD

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0012693 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von David Wullimann und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden. Hauptthemen laut MEDLINE: Encephalitis, Tick-Borne, Japanese Encephalitis Vaccines, T-Lymphocytes, Yellow Fever Vaccine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Foundation for Strategic Research, Karolinska Institutet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Flavivirus infections pose a significant global health burden, highlighting the need for safe and effective vaccination strategies. Co-administration of different vaccines, including licensed flavivirus vaccines, is commonly practiced providing protection against multiple pathogens while also saving time and reducing visits to healthcare units. However, how co-administration of different flavivirus vaccines de facto affects immunogenicity, particularly with respect to T cell responses, is only partially understood. Methods and findings Antigen-specific T cell responses were assessed in study participants enrolled in a previously conducted open-label, non-randomized clinical trial. In the trial, vaccines against tick-borne encephalitis virus (TBEV), Japanese encephalitis virus (JEV), or yellow fever virus (YFV) were administered either individually or concomitantly in different combinations in healthy study participants. Peripheral blood samples were collected before vaccination and at multiple time points afterward. To analyze antigen-specific CD4+ and CD8+ T cell responses, PBMCs were stimulated with overlapping peptide pools from TBEV, JEV, YFV, and Zika virus (ZIKV) envelope (E), capsid (C), and non-structural protein 5 (NS5) viral antigens. A flow cytometry-based activation-induced marker (AIM) assay was used to quantify antigen-specific T cell responses. The results revealed remarkably similar frequencies of CD4+ and CD8+ T cell responses, regardless of whether vaccines were administered individually or concomitantly. In addition, administering the vaccines in the same or different upper arms did not markedly affect T cell responses. Finally, limited cross-reactivity was observed between the TBEV, JEV, and YFV vaccines, and related ZIKV-specific antigens.

Conclusions

TBEV or JEV vaccines can be co-administered with the live attenuated YFV vaccine without any markedly altered antigen-specific CD4+ and CD8+ T cell responses to the respective flaviviruses. Additionally, the vaccines can be delivered in the same or different upper arms without any significant altered influence on the T cell response. From a broader perspective, these results provide valuable insights into the outcome of immune responses following simultaneous administration of different vaccines for different but related pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalitis, Tick-BorneJapanese Encephalitis VaccinesT-LymphocytesYellow Fever VaccineAdultFemaleHumansMaleMiddle AgedYoung AdultAntigens, ViralCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCohort StudiesEncephalitis Virus, JapaneseEncephalitis Viruses, Tick-BorneEncephalitis, JapaneseVaccinationYellow FeverYellow fever virus

Substanzen

Antigens, ViralJapanese Encephalitis VaccinesYellow Fever Vaccine

Autor:innen und Institutionen

  • Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Clinical Sciences, Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: David Wullimann, Hans-Gustaf Ljunggren

Förderung

  • Swedish Research Council
  • Swedish Foundation for Strategic Research
  • Karolinska Institutet
  • Stiftelsen för Strategisk Forskning
  • Region Stockholm

Zitieren

APA

Wullimann, D., Sandberg, J. T., Akber, M., Löfling, M., Gredmark-Russ, S., Michaëlsson, J., Buggert, M., Blom, K., & Ljunggren, H. G. (2025). Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0012693

Vancouver

Wullimann D, Sandberg JT, Akber M, Löfling M, Gredmark-Russ S, Michaëlsson J, et al. Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0012693

BibTeX
@article{Wullimann2025,
  author = {Wullimann, David and Sandberg, John Tyler and Akber, Mira and Löfling, Marie and Gredmark-Russ, Sara and Michaëlsson, Jakob and Buggert, Marcus and Blom, Kim and Ljunggren, Hans-Gustaf},
  title = {Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0012693}
}
Kostenlos starten →